IPWatchdog

Publish Date
Consumer, Patient Groups Push for Fast Markup of ETHIC Act
IPWatchdog
Closing the PTAB Loophole: Targeting Real Threats to U.S. Innovation Without Overreaching
IPWatchdog
IPWatchdog Masters Hall of Fame: 2026 Award Recipients
IPWatchdog
Iancu Urges House Trade Subcommittee to Address Weakening of U.S. IP Rights By America’s Trading Partners
IPWatchdog
Senate IP Subcommittee Hears from Witnesses on Impact of Proposal to Compensate Artists for Radio Plays
IPWatchdog
Current and Former Lawmakers Lock Horns in Comments on USPTO’s Proposed PTAB Changes
IPWatchdog
C4IP Urges USTR to Use USMCA Joint Review to Address Shortcomings on IP Protections
IPWatchdog
Counting Patents, Not Progress: Another Misdiagnosis by I-MAK
IPWatchdog
PERA 2025 Debated in Senate IP Subcommittee Hearing, with Business Methods, Diagnostics in Focus
IPWatchdog
Amgen Attacks Academics’ False Claims About Biologic Patents
IPWatchdog
C4IP Publishes Website Addressing Misinformation Published by I-MAK
IPWatchdog
C4IP Urges FTC to Proceed with Caution on Addressing Perceived Drug Pricing Problems
IPWatchdog
News:

News:

C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents,

05/23/2024

News:

News:

Celebrating World IP Day: Is the Innovative Future Sustainable?,

04/26/2024

News:

News:

C4IP Releases First Congressional Innovation Scorecard,

03/22/2024

News:

News:

Members of Congress Blast Biden on March-In Proposal and Pandemic Accord,

02/22/2024

News:

News:

Public Comments Reveal Widespread Unity in Opposition to NIST’s March-In Rights Framework,

02/05/2024

News:

News:

Iancu, Michel and Other PTAB Masters Panelists Float Ways to Make the System Better,

01/30/2024

News:

News:

The March-In Drug Price Control Narrative Crumbles While Its Damage to American Innovation Grows,

01/29/2024

News:

News:

Witnesses Clash Over Potential Pros and Cons of PERA in Senate IP Subcommittee Hearing,

01/23/2024

News:

News:

The Top U.S. FRAND / RAND Licensing Developments of 2023 Part II: Ghosts of Christmas Past and Christmas Future,

12/27/2023

News:

News:

From AI to Amgen, Here’s Everything IP that Mattered in 2023,

12/24/2023

News:

News:

Proposed Framework on March-In Rights Dubbed ‘Unprecedented’ by U.S. Chamber,

12/07/2023

News:

News:

C4IP and IP Celebrities Tell Biden to Pass on Extension of TRIPS Waiver,

12/05/2023

Scroll to Top